CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
China Resources Pharma (03320) announced that China Resources Boya Bio-pharmaceutical Group recorded total operating revenue of RMB847 million (same unit below) for the nine months ended September 30, 2026, a year-on-year decrease of 42.54%; net profit was RMB60.5883 million, a year-on-year decrease of 82.34%.
CHINARES PHARMA (03320) announced that China Resources Boya Bio-pharmaceutical Group recorded total operating revenue of RMB847 million (same unit below) for the nine months ended September 30, 2026, a year-on-year decrease of 42.54%; net profit was RMB60.5883 million, a year-on-year decrease of 82.34%.
Related Articles
BAMA TEA (06980) repurchased 100,000 shares on October 29 for HK$1.897 million.
CHINA POWER (02380) issues RMB1.5 billion medium-term notes
BAIRONG AI-W (06608) repurchased 70,000 shares on October 29 for HK$418,200.
BAMA TEA (06980) repurchased 100,000 shares on October 29 for HK$1.897 million.
CHINA POWER (02380) issues RMB1.5 billion medium-term notes
BAIRONG AI-W (06608) repurchased 70,000 shares on October 29 for HK$418,200.
